USPTO serial 79447348
ANTEOBIND
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEY,THOMAS S
- Law office
- TMO LAW OFFICE 130
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ANTEOBIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biochemical preparations for diagnostic use; chemical diagnostic reagents for medical use; chemical preparations for diagnostic purposes (medical); chemical products for diagnostic purposes (medical or veterinary); chemical products for diagnostic use (medical); chemical products for diagnostic use (veterinary); clinical diagnostics for medical or veterinary use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for detecting plaque; diagnostic preparations for gynaecological purposes; diagnostic preparations for gynaecological testing purposes; diagnostic preparations for medical laboratory use; diagnostic preparations for medical purposes; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical use in-vivo diagnosis; diagnostic preparations for veterinary purposes; diagnostic products for medical purposes; diagnostic reagents for in-vitro use (medical); diagnostic reagents for medical laboratory use; diagnostic reagents for medical use; diagnostic reagents for medical use for sale in kit form; diagnostic scanning agents for in-vivo use (medical); diagnostic substances for medical use; diagnostic testing materials for medical use; immunocytochemistry diagnostic preparations for medical use; in vivo medical diagnostic scanning agents for medical use; in-vivo diagnostic materials medical use; in-vivo diagnostic preparations medical use; in-vivo diagnostic reagents medical use; monoclonal antibodies for diagnostic use (medical); preparations for diagnostic purposes (medical); preparations for medical diagnostic use; reagents for use in diagnostic pregnancy tests; reagents for use in diagnostic tests (for medical purposes); reagents for use in diagnostic tests (for veterinary purposes); test erythrocytes for blood diagnostic purposes; veterinary diagnostic reagents; biological reagents for use in embryology; biological reagents for use in molecular biology; blood grouping reagents for medical use; chemical reagents for identification of microorganisms (medical or veterinary use); chemical reagents for laboratory use (medical or veterinary use); chemical reagents for medical or veterinary purposes; chemical reagents for use in diagnosis (medical or veterinary use); chemical reagents for use in medicine; chemical test reagents (medical); chemical test reagents (veterinary); colouring reagents for detecting dental plaque; immunoassay reagents for medical use; insemination result control diagnosis reagents (for veterinary use); laboratory reagents for medical use; monoclonal antibody reagents for medical use; nucleic acid amplification reagents for medical use; reagents for analytical purposes (for medical purposes); reagents for analytical purposes (for veterinary purposes); reagents for blood grouping (for medical purposes); reagents for blood grouping (for veterinary purposes); reagents for clinical laboratory tests; reagents for in-vitro laboratory use (for medical purposes); reagents for in-vitro laboratory use (for veterinary purposes); reagents for laboratory purposes (for medical purposes); reagents for laboratory purposes (for veterinary purposes); reagents for medical research applications (for diagnosis); reagents for microbiological analysis (for medical purposes); reagents for microbiological analysis (for veterinary purposes); reagents for protein folding (for medical purposes); reagents for protein folding (for veterinary purposes); reagents for testing aqueous solutions (for medical purposes); reagents for testing aqueous solutions (for veterinary purposes); reagents for use in analysis (for medical purposes); reagents for use in analysis (for veterinary purposes); reagents for use in analytical tests (for medical purposes); reagents for use in analytical tests (for veterinary purposes); reagents for use in biological processing (for medical purposes); reagents for use in biological processing (for veterinary purposes); reagents for use in medical diagnosis; reagents for use in the development of monoclonal antibodies (for medical purposes); reagents for use in the development of monoclonal antibodies (for veterinary purposes); reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) (for medical purposes); reagents in kit form for conducting enzyme-linked immunosorbent assays (elisa) (for veterinary purposes); test reagents for medical diagnosis; test reagents for medical use; testing reagents for medical use in detecting allergenic substances; universal reagents for automated test systems (medical). | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 21, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 21, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 2, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |